Novo Nordisk
NVO
#86
Rank
NZ$346.23 B
Marketcap
NZ$78.11
Share price
-2.72%
Change (1 day)
-28.77%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): NZ$42.76 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are NZ$51.37 Billion. In 2025 the company made an earning of NZ$35.74 Billion, an increase over its 2024 earnings that were of NZ$33.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$42.76 B19.64%
2025 NZ$35.74 B6.28%
2024 NZ$33.63 B28.01%
2023 NZ$26.27 B57.81%
2022 NZ$16.64 B5.24%
2021 NZ$15.82 B12.38%
2020 NZ$14.07 B13.11%
2019 NZ$12.44 B-3.45%
2018 NZ$12.89 B1.88%
2017 NZ$12.65 B4.3%
2016 NZ$12.13 B10.32%
2015 NZ$10.99 B7.47%
2014 NZ$10.23 B3.4%
2013 NZ$9.89 B19.09%
2012 NZ$8.30 B15.58%
2011 NZ$7.18 B16.58%
2010 NZ$6.16 B25.66%
2009 NZ$4.90 B10.68%
2008 NZ$4.43 B55.82%
2007 NZ$2.84 B7.02%
2006 NZ$2.65 B19.05%
2005 NZ$2.23 B10.55%
2004 NZ$2.02 B
2002 NZ$1.40 B-14.39%
2001 NZ$1.64 B-52.82%
2000 NZ$3.48 B250%
1999 NZ$0.99 B31.21%
1998 NZ$0.75 B34.31%
1997 NZ$0.56 B11.46%
1996 NZ$0.50 B9.03%
1995 NZ$0.46 B-3.15%
1994 NZ$0.47 B-0.67%
1993 NZ$0.48 B45.38%
1992 NZ$0.33 B-13.81%
1991 NZ$0.38 B37.12%
1990 NZ$0.28 B-0.79%
1989 NZ$0.28 B26.2%
1988 NZ$0.22 B24.97%
1987 NZ$0.17 B-0.9%
1986 NZ$0.18 B-7.78%
1985 NZ$0.19 B24.87%
1984 NZ$0.15 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.06 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.08 B 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.06 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$16.36 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA